Comparative Study [inpr]
Effect [qlco]
Continuous [idcn]
Combined [qlco]
Conjugated [spco]
Equine [mamm]
Estrogen [horm, phsu, strd]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
tibolone [phsu, strd]
Blood [tisu]
Background [cnce]
Hormone Therapy [topp]
Menopause [phsf]
Associated [qlco]
Increased [qnco]
Risk [qlco]
Venous Thromboembolism [patf]
tibolone [phsu, strd]
pharmacodynamic [biof]
properties [qlco]
Different [qlco]
Hormone preparation [mnob]
Compared [acty]
Effect [qlco]
Combined therapy [topp]
Hormone [horm]
tibolone [phsu, strd]
Inhibition [menp]
Haemostasis [ortf]
Methods [inpr]
Eight [qnco]
Post-Menopause [orgf]
Women [popg]
Assigned [ftcn]
mg% [qnco]
tibolone [phsu, strd]
Oral [spco]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
inhibitors [chvf]
Haemostasis [ortf]
Measured [qlco]
baseline [bodm]
months [tmco]
Result [ftcn]
Result [ftcn]
Two [qnco]
Group [idcn]
Women [popg]
Receive [qlco]
tibolone [phsu, strd]
Not [ftcn]
Different [qlco]
To [qlco]
Power [hcpp]
Study [mnob]
Two [qnco]
Group [idcn]
Merged [acty]
High [qlco]
Concentration [menp]
Protein S [aapp, bacs]
IU [qnco]
P NOS [aapp, imft]
High [qlco]
Activated Protein C Resistance [dsyn]
Ratio [qnco]
P NOS [aapp, imft]
Observed [ftcn]
tibolone [phsu, strd]
Group [idcn]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
Doses [qnco]
tibolone [phsu, strd]
Increased [qnco]
Activated Protein C Resistance [dsyn]
Ratio [qnco]
P NOS [aapp, imft]
Tissue factor pathway inhibitor [aapp, phsu]
Lower [spco]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
tibolone [phsu, strd]
Group [idcn]
ng/mL [qnco]
P NOS [aapp, imft]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Reduced [qlco]
Concentration [menp]
Antithrombin [aapp, phsu]
P NOS [aapp, imft]
Protein S [aapp, bacs]
P NOS [aapp, imft]
Tissue factor pathway inhibitor [aapp, phsu]
P NOS [aapp, imft]
Preparation [ftcn]
Reduced [qlco]
Concentration [menp]
P NOS [aapp, imft]
Conclusions [idcn]
tibolone [phsu, strd]
Induce [ftcn]
Few [qnco]
Pharmacological [bmod]
Alteration [idcn]
Blood [tisu]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Favorable [qlco]
Effect [qlco]
Activated Protein C Resistance [dsyn]
Ratio [qnco]
This [euka]
translate [ocac]
Low Risk [fndg]
Venous Thromboembolism [patf]
Indicated [fndg]
Clinical Data [inpr]
